Göbel, Andy <br/><br/>
Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.  [electronic resource] 

 -  Breast cancer research and treatment  Dec 2015 
 - 623-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-015-3624-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Atorvastatin--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor--drug effects<br/>Diphosphonates--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Imidazoles--administration & dosage<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Mevalonic Acid--antagonists & inhibitors<br/>Mice, Nude<br/>Osteoblasts--drug effects<br/>Rosuvastatin Calcium--administration & dosage<br/>Simvastatin--administration & dosage<br/>Xenograft Model Antitumor Assays<br/>Zoledronic Acid